• Determine previous changes within the Synagis market and predict the future market of the drug
• Examine background information on how pediatricians and pediatric specialists have used Synagis in the past
• Determine the current use of Synagis compared to previous seasons
• Predict the future use of Synagis
• Evaluate various factors regarding Synagis sales representatives
• Clarify factors that have affected Synagis use in the past and how they affect current use of the drug
• Compare Synagis to a similar drug called Numax

Products Highlighted:

• Synagis (Palavizumab)
• Numax

Topics:

• Past use of Synagis
• Future use of Synagis
• Evaluation of sales representatives for Synagis
• Factors affecting Synagis use
• Comparison of Synagis and Numax

Screening Criteria:

• Are board-certified in their specialty
• Have been in practice between 2 and 30 years
• Spend at least 75% of their professional time in clinical practice
• Have prescribed Synagis to at least 20 respiratory syncytial virus (RSV) patients in the past season (September 2005-April 2006)